Buzzberg Cup Live

u/AsAboveSoBelow322

Reddit r/ValueInvesting
· tracked since Mar 2026
Calls
1
Win Rate
100.0%
return
+40.2%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Best Calls
LNTH long +40.2%
Worst Calls
No live losers yet
Most Mentioned
LNTH ×1
Recent Calls
LNTH long 3 months ago
Win Rate 100% Long 1 Short 0
Win Rate
7d 100%
30d 100%
90d 100%
Average Return +40.2% Long Return +40.2% Short Return -
Average Return
7d +0.1%
30d +2.1%
90d +27.6%
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
LNTH Lantheus... Lantheus Holdings, Inc.
Long
Mar 09
$78.39
+40.2%
FDA approved a new formulation for PYLARIFY to increase batch sizes, and NEURACEQ sales recently jumped from $20 million to $31 million quarter-over-quarter. The new PYLARIFY formulation will expand geographic reach, while the growing US dementia crisis will turn NEURACEQ into a blockbuster product, driving significant revenue. Buy LNTH as an undervalued biotech play with a proven sales team and highly successful medical imaging products. Slower than expected adoption of NEURACEQ, competition from other imaging agents, or unforeseen regulatory hurdles.
FDA approved a new formulation for PYLARIFY to increase batch sizes, and NEURACEQ sales recently jumped from $20 million to $31 million quarter-over-quarter. The new PYLARIFY formulation will expand geographic reach, while the growing US dementia crisis will turn NEURACEQ into a blockbuster product, driving significant revenue. Buy LNTH as an undervalued biotech play with a proven sales team and highly successful medical imaging products. Slower than expected adoption of NEURACEQ, competition from other imaging agents, or unforeseen regulatory hurdles.
Healthcare
REDDIT
Showing 1 of 1 picks · sorted by mentions

u/AsAboveSoBelow322 has 1 trade ideas tracked on Buzzberg across 1 tickers since March 2026. Most covered: LNTH.